Suppression of IL-6 production and proliferation by blocking STAT3 activation in malignant soft tissue tumor cells

Takanori Shouda1, Koji Hiraoka, Setsuro Komiya

  • 1Department of Orthopedic Surgery, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan.

Cancer Letters
|January 10, 2006
PubMed

Insights

New malignant fibrous histiocytoma (MFH) cell lines were developed and studied. The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway was found to drive MFH cell growth, suggesting it as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Malignant fibrous histiocytoma (MFH) lacks an established optimal treatment.
  • Limited availability of MFH cell lines hinders research.

Purpose of the Study:

  • To establish new MFH cell lines.
  • To investigate the role of the JAK/STAT signaling pathway in MFH.
  • To explore potential therapeutic targets for MFH.

Main Methods:

  • Establishment of KHZ-MFH and SFT85-03 cell lines.
  • Analysis of the JAK/STAT signaling pathway components and activity.
  • Inhibition of JAK2 kinase with tyrphostin AG490.
  • Blockade of STAT3 activation using SOCS3 gene and dominant-negative STAT3.

Main Results:

  • MFH cells exhibited high IL-6 secretion and constitutive STAT3 activation.
  • JAK2 inhibition suppressed MFH cell growth and IL-6 secretion.
  • STAT3 blockade significantly inhibited MFH cell proliferation.

Conclusions:

  • An autocrine JAK/STAT3 signaling loop promotes MFH cell growth.
  • The JAK/STAT3 pathway represents a potential therapeutic target for MFH treatment.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...